PharmaCielo Ltd. provided revenue guidance for the second half of 2021. For the period, the company expects revenue growth to accelerate as sales agreements and initial commercial sales translate into higher recurring revenue and the shipment of additional value-added products beyond CBD isolate, with better margin profiles.